255 related articles for article (PubMed ID: 29450800)
21. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
[TBL] [Abstract][Full Text] [Related]
22. Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol.
Küch EM; Vellaramkalayil R; Zhang I; Lehnen D; Brügger B; Sreemmel W; Ehehalt R; Poppelreuther M; Füllekrug J
Biochim Biophys Acta; 2014 Feb; 1841(2):227-39. PubMed ID: 24201376
[TBL] [Abstract][Full Text] [Related]
23. Analyses of mental dysfunction-related ACSl4 in Drosophila reveal its requirement for Dpp/BMP production and visual wiring in the brain.
Zhang Y; Chen D; Wang Z
Hum Mol Genet; 2009 Oct; 18(20):3894-905. PubMed ID: 19617635
[TBL] [Abstract][Full Text] [Related]
24. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
Bu SY; Mashek MT; Mashek DG
J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
[TBL] [Abstract][Full Text] [Related]
25. The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.
Orlando UD; Garona J; Ripoll GV; Maloberti PM; Solano ÁR; Avagnina A; Gomez DE; Alonso DF; Podestá EJ
PLoS One; 2012; 7(7):e40794. PubMed ID: 22808264
[TBL] [Abstract][Full Text] [Related]
26. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
Tian W; Wang D; Wang Z; Jiang K; Li Z; Tian Y; Kang X; Liu X; Li H
Gene; 2021 Jan; 764():145094. PubMed ID: 32860898
[TBL] [Abstract][Full Text] [Related]
27. Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.
Rossi Sebastiano M; Konstantinidou G
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344914
[TBL] [Abstract][Full Text] [Related]
28. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
[TBL] [Abstract][Full Text] [Related]
29. Regulatory mechanism of fatty acid‑CoA metabolic enzymes under endoplasmic reticulum stress in lung cancer.
Liu KT; Yeh IJ; Chou SK; Yen MC; Kuo PL
Oncol Rep; 2018 Nov; 40(5):2674-2682. PubMed ID: 30132556
[TBL] [Abstract][Full Text] [Related]
30. ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.
Yang Y; Zhu T; Wang X; Xiong F; Hu Z; Qiao X; Yuan X; Wang D
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497375
[TBL] [Abstract][Full Text] [Related]
31. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
32. Astrocyte arachidonate and palmitate uptake and metabolism is differentially modulated by dibutyryl-cAMP treatment.
Seeger DR; Murphy CC; Murphy EJ
Prostaglandins Leukot Essent Fatty Acids; 2016 Jul; 110():16-26. PubMed ID: 27255639
[TBL] [Abstract][Full Text] [Related]
33. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
34. Adaptive evolution of the ACSL gene family in Carnivora.
Zhao C; Liu G; Shang S; Wei Q; Zhang L; Xia T; Yang X; Sun G; Zhang H
Genetica; 2019 Apr; 147(2):141-148. PubMed ID: 30868352
[TBL] [Abstract][Full Text] [Related]
35. [Research advances on the role of ACSL3 in the atherosclerosis].
Yang L; Yuan ZH
Sheng Li Xue Bao; 2023 Aug; 75(4):587-594. PubMed ID: 37583046
[TBL] [Abstract][Full Text] [Related]
36. Long-chain acyl-CoA synthetase-4 regulates endometrial decidualization through a fatty acid β-oxidation pathway rather than lipid droplet accumulation.
Zhang H; Sun Q; Dong H; Jin Z; Li M; Jin S; Zeng X; Fan J; Kong Y
Mol Metab; 2024 Jun; 84():101953. PubMed ID: 38710444
[TBL] [Abstract][Full Text] [Related]
37. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet.
Mashek DG; Li LO; Coleman RA
J Lipid Res; 2006 Sep; 47(9):2004-10. PubMed ID: 16772660
[TBL] [Abstract][Full Text] [Related]
38. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
Wu M; Liu H; Chen W; Fujimoto Y; Liu J
Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
40. Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway.
Ohkuni A; Ohno Y; Kihara A
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):195-201. PubMed ID: 24269233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
